Board Meetings for ASTEC
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ASTEC | Astec LifeSciences Limited | 29 Jan 2016 | Results/Others | To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the Quarter ended December 31, 2015 after these results are reviewed by the Audit Committee. | |
| ASTEC | Astec LifeSciences Limited | 06 Nov 2015 | Results/Others | To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2015 after these results are reviewed by the Audit Committee. | |
| ASTEC | Astec LifeSciences Limited | 25 Jul 2015 | Results/Others | To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2015 after these results are reviewed by the Audit Committee. | |
| ASTEC | Astec LifeSciences Limited | 16 May 2015 | Results/Dividend | Inter alia, to transact the following business: 1. To consider and approve the Standalone & Consolidated Audited Accounts for the Quarter & Year Ended March 31, 2015, after these accounts are reviewed by Audit Committee. 2. To recommend dividend on Equity shares for the year ended March 31, 2015, if any. 3. Any other matter with the permission of chair. | |
| ASTEC | Astec LifeSciences Limited | 05 Mar 2015 | Reappointment | To transact the following business: 1. Re-appointment of Mr. Ashok V. Hiremath as Managing Director subject to the approval of members. 2. Re-appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. 3. Any other business with the permission of Chair. | - |
| ASTEC | Astec LifeSciences Limited | 31 Jan 2015 | Results/Others | Inter alia, to consider following business: 1) to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014, after these results are reviewed by the Audit Committee, in terms of the provisions of clause 41 of the Listing Agreement and; 2) to consider allotment of 9,25,925 Equity Shares of Rs. 10/- each fully paid-up at Rs. 108/ - per share (including a premium of Rs. 98/- per share) on preferential basis to select persons/entities belonging to Non-Promoter Group, consequent to the approval of shareholders of the Company through Postal Ballot on January 20, 2015. Private placement offer letter is being sent to the select persons/entities belonging to Non-Promoter Group, as approved by Shareholders of the Company by passing of Special Resolution through Postal Ballot on January 20, 2015. 3) Any other matter with the permission of Chair. | - |
| ASTEC | Astec LifeSciences Limited | 19 Dec 2014 | Others | To consider and approve following items of agenda: 1) To consider and approve the issue and allotment of Equity shares on Preferential basis of Rs.10,00,00,000/- (Rupees Ten Crores Only) including premium thereon, to select persons/entities on such terms and conditions and at such price not lower than the price to be determined by SEBI (ICDR) Regulations, subject to the approval of members. 2) To approve the borrowing limits of the Company in compliance with the provisions of Section 180(1)(c) of the Companies Act, 2013. 3) To approve creation of charges on the assets of the Company in compliance with the provisions of Section 180(1)(a) of the Companies Act, 2013. 4) To grant Employee Stock Options to the employees of subsidiary companies of Astec LifeSciences Limited in compliance with terms and conditions of ESOP Scheme 2012, subject to the approval of members. 5) To authorize Director of the Company or Company Secretary to obtain the approval of members by way of conducting Postal ballot for item nos. 1, 2, 3 & 4 above. 6) Any other matter with the permission of Chair. | - |
| ASTEC | Astec LifeSciences Limited | 18 Oct 2014 | Results | To consider and approve amongst other items of agenda , the Unaudited Financial Results of the Company for the quarter ended September 30, 2014 after these results are reviewed by the Audit Committee. Further the Company's Code of Conduct for (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of unaudited financial results of the Company for the quarter ended September 30, 2014 for all the Officers and Designated Employees (including Directors) of the Company from October 09, 2014 till 24 hours after the announcement of the financial results of the Company to the Stock Exchanges (both days inclusive). Accordingly all Officers and Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window. | - |
| ASTEC | Astec LifeSciences Limited | 09 Aug 2014 | Results/Others | Inter-alia, to transact the following business: (1) To consider and approve the Unaudited financial accounts for the Quarter ended June 30, 2014, after these accounts are reviewed by Audit Committee.(2) To increase the Authorised Capital of the Company.(3) To alter Memorandum and Articles of Association of Company to give effect to item no.2 above. | - |
| ASTEC | Astec LifeSciences Limited | 30 May 2014 | Results/Dividend | Inter alia, to transact the following business :(1). To consider and approve the Standalone & Consolidated Audited Accounts for the Quarter & Year Ended March 31, 2014, after these accounts are reviewed by Audit Committee.(2). To recommend dividend on Equity shares for the year ended March 31, 2014, if any.(3). To discuss issuance of securities on Preferential basis by way of issue of Equity Shares/Preference Shares/Convertible Warrants/Cumulative Convertible Preference Shares/Cumulative Convertible Bonds/Debentures not exceeding Rupees 25 Crores (shall include premium thereon). (4). To increase the Authorised Capital of the Company to give effect to item no. 3 above (5). To alter Memorandum and Articles of Association of Company to give effect to item no. 3 & 4 above. | |
| ASTEC | Astec LifeSciences Limited | 14 May 2014 | Results/Dividend | Inter alia, to transact the following business: (1) To consider and approve the Standalone & Consolidated Audited Accounts for the Quarter & Year Ended March 31, 2014, after these accounts are reviewed by Audit Committee. (2). To recommend dividend on Equity shares for the year ended March 31, 2014, if any. | - |
| ASTEC | Astec LifeSciences Limited | 24 Jan 2014 | Results/Others | To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2013 after these results are reviewed by the Audit Committee. | - |
| ASTEC | Astec LifeSciences Limited | 23 Oct 2013 | Results/Others | To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2013 after these results are reviewed by the Audit Committee. | - |
| ASTEC | Astec LifeSciences Limited | 19 Sept 2013 | Allotment of Securities | For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. | - |
| ASTEC | Astec LifeSciences Limited | 12 Aug 2013 | Results | To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2013 after these results are reviewed by the Audit Committee. | - |